Clinical Trial Update: Predictors of the Response to Adalimumab in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining predictors of response to adalimumab in patients with rheumatoid arthritis. The report aims to identify factors associat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED